Inspire Medical Systems, Inc. (2DR.F)
- Previous Close
134.35 - Open
131.45 - Bid --
- Ask --
- Day's Range
131.05 - 131.45 - 52 Week Range
114.65 - 205.50 - Volume
9 - Avg. Volume
0 - Market Cap (intraday)
4.023B - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
67.21 - EPS (TTM)
1.95 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
www.inspiresleep.comRecent News: 2DR.F
View MorePerformance Overview: 2DR.F
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2DR.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2DR.F
View MoreValuation Measures
Market Cap
4.02B
Enterprise Value
3.72B
Trailing P/E
66.98
Forward P/E
64.52
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.36
Price/Book (mrq)
6.81
Enterprise Value/Revenue
4.96
Enterprise Value/EBITDA
51.47
Financial Highlights
Profitability and Income Statement
Profit Margin
7.92%
Return on Assets (ttm)
4.40%
Return on Equity (ttm)
10.86%
Revenue (ttm)
840.11M
Net Income Avi to Common (ttm)
66.51M
Diluted EPS (ttm)
1.95
Balance Sheet and Cash Flow
Total Cash (mrq)
369.19M
Total Debt/Equity (mrq)
5.27%
Levered Free Cash Flow (ttm)
42.41M